Literature DB >> 12237882

Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation.

Osami Kudo1, Yosuke Fujikawa, Ichiro Itonaga, Afsie Sabokbar, Takehiko Torisu, Nicholas A Athanasou.   

Abstract

TNFalpha and IL-1alpha are potent stimulators of bone resorption in vivo and in vitro. Recently, it has been demonstrated that these two cytokines directly induce osteoclastogenesis in mouse marrow cultures. This study determined whether TNFalpha (+/- IL-1alpha) is also capable of inducing human osteoclastogenesis. The CD14(+) monocyte fraction of human peripheral mononuclear cells was cultured with TNFalpha +/- IL-1alpha in the presence of M-CSF. TNFalpha induced the formation of multinucleated cells (MNCs) which were positive for TRAP, VNR and cathepsin K and showed evidence of resorption pit formation. IL-1alpha stimulated TNFalpha-induced lacunar resorption two- to four-fold. Osteoprotegerin, the decoy receptor for RANKL, did not inhibit this process. Anti-human IL-1alpha neutralizing antibodies significantly inhibited resorption without inhibiting the formation of TRAP(+)/VNR(+) MNCs. These results suggest that, in the presence of M-CSF, TNFalpha is sufficient for inducing human osteoclast differentiation from circulating precursors by a process which is distinct from the RANK/RANKL signalling pathway. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237882     DOI: 10.1002/path.1190

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  73 in total

1.  Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts.

Authors:  Tao Ma; Kavitha Sadashivaiah; Nandakumar Madayiputhiya; Meenakshi A Chellaiah
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

2.  A novel osteoclast precursor cell line, 4B12, recapitulates the features of primary osteoclast differentiation and function: enhanced transfection efficiency before and after differentiation.

Authors:  Shigeru Amano; Keisuke Sekine; Lynda F Bonewald; Yoshihiro Ohmori
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

Review 3.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

4.  Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation.

Authors:  Luz M Castillo; Carlos A Guerrero; Orlando Acosta
Journal:  J Mol Histol       Date:  2017-03-25       Impact factor: 2.611

5.  Stimulation of osteoclast formation by inflammatory synovial fluid.

Authors:  Iannis E Adamopoulos; Lynett Danks; Ichiro Itonaga; Rachel M Locklin; Afsie Sabokbar; David J P Ferguson; Nicholas A Athanasou
Journal:  Virchows Arch       Date:  2006-04-21       Impact factor: 4.064

6.  IL-1alpha stimulates cathepsin K expression in osteoclasts via the tyrosine kinase-NF-kappaB pathway.

Authors:  S Kamolmatyakul; W Chen; S Yang; Y Abe; R Moroi; A M Ashique; Y-P Li
Journal:  J Dent Res       Date:  2004-10       Impact factor: 6.116

Review 7.  Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.

Authors:  A Sabokbar; D J Mahoney; F Hemingway; N A Athanasou
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

Review 8.  Chronic pediatric inflammatory diseases: effects on bone.

Authors:  Anuradha Viswanathan; Francisco A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2007-12-29       Impact factor: 6.514

9.  Osteopetrosis with micro-lacunar resorption because of defective integrin organization.

Authors:  Harry C Blair; Beatrice B Yaroslavskiy; Lisa J Robinson; Markus Y Mapara; Alessandra Pangrazio; Lida Guo; Ka Chen; Paolo Vezzoni; Jakub Tolar; Paul J Orchard
Journal:  Lab Invest       Date:  2009-06-22       Impact factor: 5.662

10.  Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.

Authors:  Guillaume Mabilleau; Afsie Sabokbar
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.